# Study to Assess the Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia

> **NCT00537680** · PHASE3 · COMPLETED · sponsor: **Santhera Pharmaceuticals** · enrollment: 70 (actual)

## Conditions studied

- Friedreich's Ataxia

## Interventions

- **DRUG:** Idebenone
- **DRUG:** Idebenone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00537680
- **Lead sponsor:** Santhera Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2023-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00537680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00537680, "Study to Assess the Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00537680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*